LeMaitre Vascular (LMAT) director gains stock through PSU vesting and dividend rights
Rhea-AI Filing Summary
LEMAITRE VASCULAR director Joseph P. Pellegrino Jr. reported share acquisitions tied to equity compensation, not open-market buying or selling. On February 26, 2026, he received 1,893 shares of common stock as part of a performance share unit (PSU) award granted on December 6, 2024, after 25% of the award vested upon satisfaction of a performance condition.
He also acquired 4 dividend equivalent rights, which were exercised into 4 shares of common stock at a price of $0.00 per share. Each dividend equivalent right is the economic equivalent of one share of common stock and was released in connection with the PSU vesting. Following these transactions, he directly owned 12,080 shares of common stock and 11.4826 dividend equivalent rights, reflecting routine equity-based compensation rather than discretionary trading.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Dividend Equivalent Rights | 4 | $0.00 | -- |
| Grant/Award | Common Stock | 1,893 | $0.00 | -- |
| Exercise | Common Stock | 4 | $0.00 | -- |
Footnotes (1)
- These shares represent LMAT common stock acquired on February 26, 2026, upon settlement of a Performance Share Unit (PSU) award granted on December 6, 2024. The PSU award vested 25% upon determination of satisfaction of the performance condition (on 2/26/2026), and the balance vests in equal annual installments on the grant date anniversary over the next three years. Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. These dividend equivalent rights were released in connection with the vesting of a PSU award granted on December 6, 2024. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.